Sandu Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Sandu Pharmaceutical	Kabra Drugs	ANG Lifesciences
Operational Metrics
Financials
5 yr Average ROE	3.94 %	65.41 %	11.51 %
5yr average Equity Multiplier	1.34	-11.28	3.24
5yr Average Asset Turnover Ratio	1.27	0.0	0.88
5yr Avg Net Profit Margin	2.31 %	0.0	1.44 %
Price to Book	1.09	1.87	0.7
P/E	29.39	0.0	0.0
5yr Avg Cash Conversion Cycle	27.73 Days	0.0	57.8 Days
Inventory Days	71.51 Days	0.0	76.41 Days
Days Receivable	26.2 Days	0.0	195.39 Days
Days Payable	79.23 Days	0.0	179.71 Days
5yr Average Interest Coverage Ratio	28.27	-836.53	2.65
5yr Avg ROCE	5.77 %	64.57 %	22.81 %
5yr Avg Operating Profit Margin	3.87 %	0.0	10.92 %
5 yr average Debt to Equity	0.0	-6.16	0.87
5yr CAGR Net Profit	-1.69 %	65.28 %	n/a
5yr Average Return on Assets	2.94 %	-21.32 %	3.23 %
Shareholdings
Promoter Holding	42.9 %	0.0	70.6 %
Share Pledged by Promoters	0.0	0.0	44.88 %
Change in Promoter Holding (3 Yrs)	-7.53 %	0.0	-0.55 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0